О Rosa biotech

О компании

Rosa Biotech is redefining biosensing. They are enabling previously intractable challenges in early disease diagnosis and industrial biotechnology to be addressed accurately and at scale. Their patent-pending technology builds upon and extends the pioneering protein design work of Prof. Dek Woolfson and his team at the University of Bristol’s Synthetic Biology Research Centre, BrisSynBio. By combining this with advanced machine-learning techniques, they offer a powerful platform capable of being trained to address numerous complex biosensing problems.